World TB Day 2020

It's Time to End TB - CDC DGHT World TB Day 2020

Each year on March 24, CDC joins the global community to recognize World Tuberculosis (TB) Day – an important moment to unite in renewed commitment to ending TB, an airborne disease that knows no borders.

In partnership with host-country governments, CDC is on the frontlines helping to sustain country-led efforts and to drive progress in this effort, bringing to bear a combination of scientific expertise and on-the-ground experience in diagnosing, curing, and preventing all forms of TB at home and around the world.

Leadership Statement

CDC Director Dr. Robert Redfield discusses progress to date in the fight against TB and the need to accelerate efforts to control this epidemic at home and abroad.

avatar of CDC Director Robert RedfieldMessage from the CDC Director Robert R. Redfield, MD
World TB Day is observed annually on March 24th to commemorate Dr. Robert Koch’s announcement of his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). Worldwide, TB remains the world’s deadliest infectious disease killer with an estimated 10 million people developing TB disease each year, and approximately 4,100 persons losing their lives every day. Globally, CDC is on the frontlines in the world’s highest burden countries to find, cure, and prevent all forms of TB. Our work helps to expand access to improved diagnostic methods; strengthen and expand laboratory capacity, surveillance systems, and prevention and treatment programs; and build workforce and research capacity.
Click here for the full message.

Message from Hank Tomlinson, PhD, Director of CDC’s Division of Global HIV & TB
“We are at a key moment in the global fight against tuberculosis. Tremendous progress has been made and, yet, this preventable, curable infection still claims more lives than any other infectious disease or epidemic. As leaders come together on World TB Day and again at the United Nations High Level Meeting on TB in September, the time has come to double down on our TB prevention programs and investments. Today, we have the tools to turn the tide against the TB epidemic; the question is, do we have the political will? I’m convinced the answer is yes.”

CDC Global on Thursday, August 24, 2017

Transforming the Fight to End TB Around the Globe

It's time to end TB: Changing the Course of the Global TB EpidemicThe global community has made substantial progress and investments in support of global initiatives to end TB. Between 2000 and 2018, more than 58 million lives were saved through global TB efforts. Today, we stand at a critical juncture in the fight to end TB worldwide. It has been almost two years since the historic United Nations High Level Meeting on TB, when Member States committed to meeting the following targets by 2022: treating 40 million people, including 3.5 million children with TB and 1.5 million people with drug-resistant TB; and providing TB preventive treatment (TPT) to 30 million people. Read More

CDC on the Frontlines

CDC stands at the forefront of global efforts to find, cure, and prevent TB.

The End of Global TB image of Sarita Shah, Associate Chief for Science Global TB Branch

Faces from the Frontlines
View images and read stories of those at the forefront of CDC’s global TB response as part of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) – individuals whose efforts and innovations are helping to transform the TB epidemic.”

IT'S TIME, END TB! World TB Day promotion

World TB Day commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacteria that causes TB. This year’s World TB Day theme “It’s TIME!” highlights CDC’s efforts to eliminate TB in the United States and around the world.

World TB Day MMWR image for article story

World TB Day MMWR
An analysis of global TB surveillance data found that in 2018, an estimated 10 million persons with incident TB and 1.5 million TB-related deaths occurred worldwide, representing 2% and 5% declines from 2017.

Latest Research

New research highlights CDC’s leadership in strengthening TB surveillance, guidelines, and laboratory systems worldwide.

  • A recent CDC analysis published in the Bio Med Central Medical journal evaluated the impact of interventions on early antiretroviral therapy (ART) mortality. Results show the interventions, aimed at strengthening intensified case finding, combined with active tracing to support patient retention were associated with increased TB case finding and lower early ART mortality.
  • In a recent study published in The Lancet, the Pneumonia Etiology Research for Child Health (PERCH) Study Group found TB to be among the top ten causes of pneumonia among hospitalized children under five years of age without HIV infection. This study, completed in African and Asian countries, continues to inform efforts to develop stronger diagnostics and treatment for children with TB as well as efforts to develop an effective vaccine.
  • In a recent study published in Emerging Infectious Diseases journal, researchers  conducted a meta-analysis for treatment outcomes among children with  bacteriologically confirmed extensively drug-resistant tuberculosis (XDR-TB) from 1999-2013.  These fourteen studies included detail of only 37 cases of XDR-TB over a 15-year period, underscoring the lack of data regarding the diagnosis and treatment of children with this most severe form of TB. However, more than 80% of the 37 children included in this study had favorable treatment outcomes with mortality rates significantly lower than adults with XDR-TB, which shows promise for successfully treating XDR-TB in children. Further evaluation of effective and safe regimens for children with XDR-TB is needed, along with better data collection for children with drug-resistant TB.
  • In a recent study published in the International Journal of Tuberculosis and Lung Disease, researchers aimed to assess current status of Tuberculosis preventive treatment (TPT) implementation in countries supported by the US President’s Emergency Plan for AIDS Relief (PEPFAR).  TPT was included in national guidelines in 33 (94%) PEPFAR countries, but only 21 (60%) reported nationwide programmatic TPT implementation. Study authors highlight improved leadership and coordination between HIV and TB programs as factors required for successful TPT scale up.

Global TB Elimination Champions

On World TB Day 2020, CDC’s “Global TB Elimination Champions” highlights organizations, individuals, and initiatives that have made meaningful contributions to end TB around the world. Click on the drop-down links below for more information on the unique contributions of these TB champions toward ending global TB.


CDC’s Division of Global HIV & TB offers these resources, which can be shared across various networks in the lead-up to World TB Day and year-round.

Multidrug Resistant TB Factsheet

This brief overview describes CDC’s response to the global threat of multidrug-resistant tuberculosis

TB Fact Sheet

An overview of CDC’s global TB efforts and return on investments in responding to one of the world’s greatest health threats

Social Media Cards

Shareable social media graphics that highlight the burden of TB, global progress to date, and CDC’s leadership to help end the epidemic